Open AccessINFERIOR OUTCOMES OF BASILIXIMAB COMPARE TO ANTI-THYMOCYTE GLOBULIN INDUCTION THERAPY IN KIDNEY TRANSPLANTATION WITH WEAK PRETRANSPLANT DONOR SPECIFIC ANTI-HLA ANTIBODY
Author(s) -
Hyunmin Ko,
Seok-Ki Min,
Ahram Han,
Hyejin Mo,
Chris Changwha Chung,
Hyo Kee Kim,
JongWon Ha
Publication year - 2020
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/01.tp.0000700404.96761.a6
Subject(s) - basiliximab , medicine , rituximab , panel reactive antibody , plasmapheresis , thymoglobulin , anti thymocyte globulin , kidney transplantation , gastroenterology , transplantation , alemtuzumab , urology , single center , tacrolimus , antibody , immunology